In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469

By Urban C.   Hamacher A.   Partke H.   Roden M.   Schinner S.   Christiansen E.   Due-Hansen M.   Ulven T.   Gohlke H.   Kassack M.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 386, Iss. 12, 2013-12 ,pp. : 1021-1030

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses

By Willoughby S.R.   Chirkov Y.Y.   Kennedy J.A.   Murphy G.A.   Chirkova L.P.   Horowitz J.D.  

European Journal of Pharmacology, Vol. 356, Iss. 2, 1998-09 ,pp. : 207-213

Elsevier

Access to resources Recommend Favorite

Long-Chain Omega-3 Fatty Acid Deficiency in Mood Disorders: Rationale for Treatment and Prevention

By  

Current Drug Discovery Technologies, Vol. 10, Iss. 3, 2013-09 ,pp. : 233-244

Bentham Science Publishers

Access to resources Recommend Favorite

ABC Subfamily D Proteins and Very Long Chain Fatty Acid Metabolism as Novel Targets in Adrenoleukodystrophy

By  

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 694-706

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative Structure Activity Relationship Studies on a Novel Indolediones as Long Chain Fatty Acid Elongase 6 (ELOVL6) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 5, 2011-06 ,pp. : 422-429

Bentham Science Publishers

Access to resources Recommend Favorite